Vendor, Morrisville, NC
Ad Astra Diagnostics, Inc.
UEI LED6PKVTAH33, CAGE 9STN1
1 award and $6,702,732 obligated between September 19, 2024 and April 13, 2026, 100% under full and open competition, against 99.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | $6,702,732 |
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $6,702,732 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50124C00053Definitive Contract, September 19, 2024, Full and Open Competition, 99 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Ad Astra Diagnostics, INC. (Plus) &D for Clia-Waived Ubiquitous Early Sepsis Detection, Severity in Ambulance, Pre-Hospital, Post- DischargeNAICS 541714, PSC AN13 | $6,702,732 |
- Places of performance
- North Carolina
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 6 across 1 awards